oral oxycodone for Pediatric Surgical Patients

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Pediatric Surgical Patientsoral oxycodone - Drug
Eligibility
< 18
All Sexes
What conditions do you have?
Select

Study Summary

This trial will help researchers learn more about how the commonly prescribed painkiller oxycodone affects children by studying its metabolic activity and performing genetic testing.

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: The 10 samples will be drawn at the following time points: 8 blood samples will be taken at 30 minutes, 1, 1.5, 2, 3, 4, 5, and 6 hours post-dose in every patient along other 2 samples at approximately either 8 and 12 or 10 and 24 hours post-dose.

Hour 24
Oxycodone, oxymorphone, noroxymorphone and noroxycodone serum levels

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

1 Treatment Group

oral oxycodone
1 of 1

Experimental Treatment

68 Total Participants · 1 Treatment Group

Primary Treatment: oral oxycodone · No Placebo Group · Phase 4

oral oxycodone
Drug
Experimental Group · 1 Intervention: oral oxycodone · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: the 10 samples will be drawn at the following time points: 8 blood samples will be taken at 30 minutes, 1, 1.5, 2, 3, 4, 5, and 6 hours post-dose in every patient along other 2 samples at approximately either 8 and 12 or 10 and 24 hours post-dose.

Who is running the clinical trial?

Boston Children's HospitalLead Sponsor
717 Previous Clinical Trials
5,324,683 Total Patients Enrolled
Patcharee Sriswasdi, MDPrincipal Investigator - Boston Children Hospital
Boston Children's Hospital, Chmc Anesthesia Foundation Inc

Eligibility Criteria

Age < 18 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: